SCHEMBL3365101

SCHEMBL3365101

CCCCNS(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1158769 0.92 PPARA (0.58)
SCHEMBL11221936 0.90 PPARA (0.61)
SCHEMBL10930258 0.90 PPARA (0.61)
SCHEMBL1111454 0.83
SCHEMBL245387 0.78
Butyl(Butylsulfamoyl)Amine SCHEMBL2486301 0.78 CA1 (1.00)
SCHEMBL277303 0.76 CA1 (0.67)
SCHEMBL8679104 0.76 CA1 (0.67)
SCHEMBL2111624 0.76
SCHEMBL487521 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303503-B1 ANILINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-01-27 EP disclosed
EP-1797077-A4 BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF I ASTRAZENECA AB (SE) 2009-04-01 EP disclosed
EP-1311475-B1 AMINOCYCLOHEXANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-08-06 EP disclosed
US-7335687-B2 2,3-Oxidosqualene-lanosterol cyclase inhibitors HOFFMANN-LA ROCHE INC. (US) 2008-02-26 US disclosed
EP-1797077-A1 BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND USES THEREOF I AstraZeneca AB (SE) 2007-06-20 EP disclosed
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP disclosed
US-7202258-B2 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 2007-04-10 US disclosed
US-7189756-B2 Pyrrolidine derivatives HOFFMAN-LA ROCHE INC. (US) 2007-03-13 US disclosed
US-7102007-B2 Dihydroindole and tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2006-09-05 US disclosed
US-7071212-B2 N-(4-carbamimidoyl-phenyl)-glycine derivatives HOFFMANN-LA ROCHE INC. (US) 2006-07-04 US disclosed
US-4704388-A ANTIULCER, CYTOPROTECTIVE RORER PHARMACEUTICAL CORPORATION (US) 1987-11-03 US disclosed
EP-0185684-A4 3- AND 5- ADBICYCLIC ETHER OR BICYCLIC ALKYLENE THIOETHER BDALKYLENE AMINO THIATRIAZINES, AND THEIR PHARMACEUTICAL USES. RORER INTERNAT OVERSEAS INC (US) 1986-09-22 EP disclosed
EP-0185684-A1 3- AND 5- ADBICYCLIC ETHER OR BICYCLIC ALKYLENE THIOETHER BDALKYLENE AMINO THIATRIAZINES, AND THEIR PHARMACEUTICAL USES RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1986-07-02 EP disclosed
WO-1985005105-A1 3- AND 5- ADBICYCLIC ETHER OR BICYCLIC ALKYLENE THIOETHER BDALKYLENE AMINO THIATRIAZINES, AND THEIR PHARMACEUTICAL USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1985-11-21 WO disclosed
US-4327034-A CHEMICAL INTERMEDIATE PREPARED FROM A SULFAMIC ACID HALIDE AND A HALOGEN COMPOUND BASF AKTIENGESELLSCHAFT (DE) 1982-04-27 US disclosed
EP-0009054-A1 N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same MERCK & CO. INC. (US) 1980-04-02 EP disclosed
US-4115573-A N-pyrazinecarbonyl-N'-substituted-sulfamoylguanidine and processes for preparing same MERCK & CO., INC. (US) 1978-09-19 US disclosed
US-4096181-A Substituted sulfamic acid halides BASF AKTIENGESELLSCHAFT (DT) 1978-06-20 US disclosed
US-3992444-A BY REACTION OF A SULFAMIC ACID WITH AN ACID HALIDE BASF AKTIENGESELLSCHAFT (DT) 1976-11-16 US disclosed
US-3935201-A Production of 2,1,3-benzothiadiazin-4-one-2,2-dioxides BASF AKTIENGESELLSCHAFT (DT) 1976-01-27 US disclosed